Masimo (NASDAQ:MASI) Reaches New 1-Year High – Should You Buy?

Masimo Corporation (NASDAQ:MASI) hit a new 52-week high on Friday . The stock traded as high as $179.00 and last traded at $178.9450, with a volume of 220634 shares. The stock had previously closed at $178.90.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on MASI shares. BTIG Research downgraded Masimo from a “buy” rating to a “neutral” rating in a report on Wednesday, February 18th. Piper Sandler downgraded Masimo from an “overweight” rating to a “hold” rating and set a $180.00 price target on the stock. in a report on Tuesday, February 17th. Wells Fargo & Company upgraded Masimo to a “hold” rating in a report on Wednesday, March 18th. Raymond James Financial downgraded Masimo from an “outperform” rating to a “market perform” rating in a report on Friday, March 27th. Finally, Stifel Nicolaus set a $180.00 price target on Masimo in a report on Tuesday, February 17th. Nine equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $180.40.

Masimo Price Performance

The firm has a fifty day simple moving average of $178.43 and a 200 day simple moving average of $159.18. The company has a market capitalization of $9.37 billion, a PE ratio of -16.97, a P/E/G ratio of 1.81 and a beta of 1.11. The company has a debt-to-equity ratio of 0.56, a quick ratio of 1.45 and a current ratio of 2.68.

Institutional Trading of Masimo

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Global Retirement Partners LLC bought a new stake in Masimo during the 4th quarter valued at $27,000. Aster Capital Management DIFC Ltd bought a new stake in Masimo during the 4th quarter valued at $28,000. Los Angeles Capital Management LLC bought a new stake in Masimo during the 4th quarter valued at $31,000. Western Wealth Management LLC bought a new stake in Masimo during the 1st quarter valued at $44,000. Finally, Rothschild Investment LLC boosted its position in Masimo by 12,950.0% during the 4th quarter. Rothschild Investment LLC now owns 261 shares of the medical equipment provider’s stock valued at $34,000 after acquiring an additional 259 shares in the last quarter. Institutional investors own 85.96% of the company’s stock.

Masimo Company Profile

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.